Subtopic Deep Dive

Cyclodextrins in Drug Solubilization
Research Guide

What is Cyclodextrins in Drug Solubilization?

Cyclodextrins are cyclic oligosaccharides used to form inclusion complexes that enhance the aqueous solubility and stability of poorly water-soluble drugs through host-guest interactions.

Cyclodextrins feature a hydrophilic exterior and hydrophobic interior cavity that encapsulates lipophilic drug molecules. Phase solubility studies classify complexation as A_L-type (linear) or B_S-type (solubility-limited). Over 10 key papers since 1996, led by Loftsson and Brewster, document applications with >10,000 total citations.

Curated Papers

Key Challenges

Why It Matters

Cyclodextrins enable oral and parenteral delivery of BCS Class II/IV drugs like itraconazole and amphotericin B, improving bioavailability (Loftsson and Brewster, 1996; 2132 citations). They stabilize formulations against oxidation and hydrolysis, supporting products like Voriconazole CD injection (Davis and Brewster, 2004; 1940 citations). In product development, they reduce toxicity via complexation, expanding options for 40% of poorly soluble pipeline drugs (Loftsson and Brewster, 2010; 944 citations).

Key Research Challenges

Complex Stoichiometry Optimization

Determining 1:1 vs. 1:2 drug-CD ratios requires phase solubility and NMR analysis, as stoichiometry affects solubility gains (Brewster and Loftsson, 2007; 1808 citations). Misestimation leads to suboptimal formulations. Molecular modeling aids prediction but needs validation.

Stability in Biological Media

Complexes dissociate in serum due to competition from proteins and lipids, reducing efficacy (Loftsson and Duchêne, 2006; 1648 citations). pH and ionic strength further destabilize. Modified CDs like HP-β-CD improve resilience.

Toxicity and Regulatory Approval

Nephrotoxicity limits parenteral α-CD use, while γ-CD faces hemolysis issues (Loftsson et al., 2012; 794 citations). FDA approves only select CDs with safety data. Dose limits (e.g., 400 mg/kg HP-β-CD) constrain applications.

Essential Papers

Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization

Þorsteinn Loftsson, Marcus E. Brewster · 1996 · Journal of Pharmaceutical Sciences · 2.1K citations

Cyclodextrins are cyclic oligosaccharides which have recently been recognized as useful pharmaceutical excipients. The molecular structure of these glucose derivatives, which approximates a truncat...

Cyclodextrin-based pharmaceutics: past, present and future

Mark E. Davis, Marcus E. Brewster · 2004 · Nature Reviews Drug Discovery · 1.9K citations

Drug Solubility: Importance and Enhancement Techniques

Ketan T. Savjani, Anuradha Gajjar, Jignasa Savjani · 2012 · ISRN Pharmaceutics · 1.9K citations

Solubility, the phenomenon of dissolution of solute in solvent to give a homogenous system, is one of the important parameters to achieve desired concentration of drug in systemic circulation for d...

Cyclodextrins as pharmaceutical solubilizers

Marcus E. Brewster, Þorsteinn Loftsson · 2007 · Advanced Drug Delivery Reviews · 1.8K citations

Cyclodextrins and their pharmaceutical applications

Þorsteinn Loftsson, Dominique Duchêne · 2006 · International Journal of Pharmaceutics · 1.6K citations

Pharmaceutical Particle Engineering via Spray Drying

Reinhard Vehring · 2007 · Pharmaceutical Research · 1.6K citations

Cyclodextrins in drug delivery: An updated review

Rajeswari Challa, Alka Ahuja, Javed Ali et al. · 2005 · AAPS PharmSciTech · 1.2K citations

Reading Guide

Foundational Papers

Start with Loftsson and Brewster (1996; 2132 citations) for core solubilization mechanisms and phase solubility; follow with Davis and Brewster (2004; 1940 citations) for historical applications and Brewster and Loftsson (2007; 1808 citations) for solubilizer details.

Recent Advances

Study Loftsson and Brewster (2010; 944 citations) for product development challenges; Kurkov and Loftsson (2012; 794 citations) for CD properties updates.

Core Methods

Phase solubility studies (Higuchi-Connors); NMR/ROESY for inclusion proof; molecular docking (AutoDock) for K predictions; spray drying for solid dispersions (Vehring, 2007).

How PapersFlow Helps You Research Cyclodextrins in Drug Solubilization

Discover & Search

Research Agent uses searchPapers('cyclodextrin drug solubilization phase solubility') to retrieve Loftsson and Brewster (1996; 2132 citations), then citationGraph reveals forward citations like Davis and Brewster (2004), and findSimilarPapers expands to Brewster and Loftsson (2007). exaSearch queries 'HP-beta-cyclodextrin itraconazole complex stability' for formulation-specific hits.

Analyze & Verify

Analysis Agent applies readPaperContent on Loftsson and Brewster (1996) to extract phase solubility diagrams, verifyResponse with CoVe checks complex stability claims against 5 citing papers, and runPythonAnalysis fits A_L-type solubility data using NumPy least-squares for K_{1:1} constants. GRADE grading scores evidence as high for solubilization mechanisms.

Synthesize & Write

Synthesis Agent detects gaps in γ-CD parenteral applications via contradiction flagging across Challa et al. (2005) and Kurkov and Loftsson (2012), then Writing Agent uses latexEditText for phase diagrams, latexSyncCitations for 20-paper bibliography, and latexCompile generates a review manuscript with exportMermaid for inclusion complex schematics.

Use Cases

"Analyze phase solubility data from Loftsson 1996 for my indomethacin-CD complex"

Analysis Agent → runPythonAnalysis(NumPy pandas plot solubility curve) → fitted K_{1:1} and diagram exported as matplotlib figure.

"Write LaTeX review on beta-CD drug formulations with citations"

Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations(Loftsson Brewster papers) → latexCompile → PDF with diagrams.

"Find code for cyclodextrin molecular dynamics simulations"

Research Agent → paperExtractUrls (Vehring 2007) → paperFindGithubRepo → githubRepoInspect → GROMACS scripts for CD inclusion complex equilibration.

Automated Workflows

Deep Research workflow scans 50+ cyclodextrin papers via searchPapers → citationGraph → structured report with GRADE-scored solubility enhancement meta-analysis. DeepScan's 7-step chain verifies complexation claims: readPaperContent → CoVe → runPythonAnalysis on phase data. Theorizer generates hypotheses on sulfobutylether-β-CD for biologics from Loftsson et al. trends.

Try Doxa for Cyclodextrins in Drug Solubilization Research

Frequently Asked Questions

What defines cyclodextrins in drug solubilization?

Cyclodextrins are α-, β-, or γ- cyclic oligosaccharides with 6-8 glucose units forming a torus-shaped cavity for guest drug inclusion, enhancing solubility up to 1000-fold (Loftsson and Brewster, 1996).

What methods characterize CD-drug complexes?

Phase solubility diagrams (A_L or B_S types), DSC, NMR (chemical shift changes), and ITC measure binding constants K_{1:1} (Brewster and Loftsson, 2007).

What are key papers on cyclodextrins?

Loftsson and Brewster (1996; 2132 citations) on solubilization; Davis and Brewster (2004; 1940 citations) on pharmaceutics history; Brewster and Loftsson (2007; 1808 citations) on solubilizers.

What open problems exist?

Predicting complexation for novel CDs via computational models; overcoming in vivo displacement by biomolecules; scaling spray-dried CD formulations without aggregation (Loftsson and Brewster, 2010).